Literature DB >> 399622

Steroid endocrinology after the menopause: a review.

J D Hutton, H S Jacobs, V H James.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 399622      PMCID： PMC1437134          DOI： 10.1177/014107687907201109

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  22 in total

1.  Urinary oestrogens of adrenal origin in women with breast cancer.

Authors:  J B BROWN; C W FALCONER; J A STRONG
Journal:  J Endocrinol       Date:  1959-10       Impact factor: 4.286

2.  Conversion of testosterone to estrogens in castrated, adrenalectomized human females.

Authors:  C D WEST; B L DAMAST; S D SARRO; O H PEARSON
Journal:  J Biol Chem       Date:  1956-01       Impact factor: 5.157

Review 3.  Steroid dynamics under steady-state conditions.

Authors:  D T Baird; R Horton; C Longcope; J F Tait
Journal:  Recent Prog Horm Res       Date:  1969

4.  Conversion of androstenedione to estrone by human tissue.

Authors:  A E Schindler; A Ebert; E Friedrich
Journal:  J Clin Endocrinol Metab       Date:  1972-10       Impact factor: 5.958

5.  Validity of metabolic clearance and interconversion rates of estrone and 17-beta-estradiol in normal adults.

Authors:  C Longcope; J F Tait
Journal:  J Clin Endocrinol Metab       Date:  1971-04       Impact factor: 5.958

6.  Metabolism and tissue uptake of estrogen in women with advanced carcinoma of the breast.

Authors:  W H Pearlman; R De Hertogh; K R Laumas; M R Pearlman
Journal:  J Clin Endocrinol Metab       Date:  1969-05       Impact factor: 5.958

7.  Plasma precursors of estrogen. I. Extent of conversion of plasma delta-4-androstenedione to estrone in normal males and nonpregnant normal, castrate and adrenalectomized females.

Authors:  P C MacDonald; R P Rombaut; P K Siiteri
Journal:  J Clin Endocrinol Metab       Date:  1967-08       Impact factor: 5.958

8.  A study of estrogen metabolic clearance rates and transfer factors.

Authors:  W C Hembree; C W Bardin; M B Lipsett
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

9.  Relation between plasma oestrone and oestradiol and climacteric symptoms.

Authors:  J D Hutton; H S Jacobs; M A Murray; V H James
Journal:  Lancet       Date:  1978-04-01       Impact factor: 79.321

10.  Conversion of blood androgens to estrogens in normal adult men and women.

Authors:  C Longcope; T Kato; R Horton
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808
View more
  4 in total

1.  Potential value of urinary oestrogen assays in the identification of fast bone losers after the menopause.

Authors:  M H Walkinshaw; P A Mole; C R Paterson
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

2.  Characterizing the trajectories of vasomotor symptoms across the menopausal transition.

Authors:  Ping G Tepper; Maria M Brooks; John F Randolph; Sybil L Crawford; Samar R El Khoudary; Ellen B Gold; Bill L Lasley; Bobby Jones; Hadine Joffe; Rachel Hess; Nancy E Avis; Sioban Harlow; Daniel S McConnell; Joyce T Bromberger; Huiyong Zheng; Kristine Ruppert; Rebecca C Thurston
Journal:  Menopause       Date:  2016-10       Impact factor: 2.953

3.  Vasomotor symptoms and lipids/lipoprotein subclass metrics in midlife women: Does level of endogenous estradiol matter? The SWAN HDL Ancillary Study.

Authors:  Alexis Nasr; Karen A Matthews; Maria M Brooks; Daniel S McConnell; Trevor J Orchard; Jeffrey Billheimer; Daniel J Rader; Samar R El Khoudary
Journal:  J Clin Lipidol       Date:  2020-07-08       Impact factor: 4.766

4.  Sex hormones and immune dysregulation in multiple myeloma.

Authors:  H Everaus; J Lehtmaa
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.